Anti-CD66c / d Antibody

Rabbit polyclonal antiserum raised against the human CD66c and CD66d antigens, members of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM) family of immunoglobulin-superfamily glycoproteins. Supplied unconjugated at 100 µl per vial, the reagent is validated for Western blot and ELISA applications on human samples and is used in studies of granulocyte biology, epithelial cell adhesion, and CEACAM6 overexpression in solid tumours including colorectal, pancreatic, and non-small-cell lung carcinoma. CD66d additionally serves as a granulocyte receptor implicated in opsonin-independent recognition and phagocytosis of bacterial pathogens, extending the reagent's use to innate-immunity research. The Antibodies.com polyclonal is produced in rabbit and binds the native CD66c/CEACAM6 target, serving as a primary detection reagent for probing neutrophil differentiation markers and tumour-associated surface antigens in immunoblotting and immunoassay workflows.